JUL 22, 2020 10:00 AM PDT

Molecular Diagnostic Solutions in a Pandemic: Planning for the 2020/2021 Flu Season with the Implementation of the ePlex® Respiratory Pathogen Panel 2

Sponsored by: GenMark Dx
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Assistant Professor of Pathology, Director, Molecular Virology, Johns Hopkins Medicine
    Biography
      Dr. Heba Mostafa completed her M.D. at the Faculty of Medicine, Alexandria University, Egypt in 2004 which was followed by a period of training and residency in clinical pathology. After completion of her M.D., she moved to the United States where she earned her Ph.D. in Microbiology in 2014 at the University of Kansas. In the 3 years following, she completed a Post-Doctoral Research Fellowship at St. Jude Children's Research Hospital where she focused on studying the pathogenesis, spread, and clearance of parainfluenza and influenza viruses in immunocompromised hosts.

      Upon completion of her research fellowship, Dr. Mostafa completed a two year Clinical Microbiology Fellowship at the University of Rochester Medical Center (URMC), where she was involved in the implementation of whole genome sequencing in the clinical microbiology laboratory. After her two year fellowship, she became board certified in Medical Microbiology by the American Society for Microbiology.

      While large amounts of her work have been presented and published on many topics, her current research interests include genomic surveillance of viruses and the correlation between viral evolution and disease severity. Dr. Mostafa is keen to understand more about the respiratory virome and developing personalized molecular diagnostic panels for immunocompromised populations as well as implementation of innovative molecular diagnostics in the clinical microbiology laboratory.

      Currently, she is the Director of Molecular Virology and an Associate Professor of Pathology at Johns Hopkins Medicine where she has been at the forefront of the pandemic, managing routine respiratory pathogen testing for Johns Hopkins and implementation of SARS-CoV-2 testing. In the rapidly evolving diagnostic landscape of 2020, Dr. Mostafa's interests are focused on developing future testing algorithms for respiratory pathogens that include SARS-CoV-2 to continually meet the needs of patient care.

    Abstract

    DATE: July 22, 2020

    TIME:  10:00 am PDT

     

    The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnostic testing became clear while many other factors regarding implementation and the future of testing remained in limbo with questions unanswered.

    Many laboratorians alongside their clinical colleagues have had to implement solutions for their patients that made the most sense and were the best fit for their institution.  This has led to building a laboratory test ordering framework which includes multiple platforms for SARS-CoV-2 testing to co-exist with other respiratory pathogen tests already in place, as the influenza season began to trail off. 

    Dr. Heba Mostafa and her team have taken a non-conventional approach to guide and build a testing algorithm for the detection of SARS-CoV-2 and other respiratory pathogens at the Johns Hopkins Virology Laboratory. In this webinar, she will detail her experience, early on, in the pandemic for SARS-CoV-2 testing and the considerations taken for using different testing methods. She will also highlight how the implementation of the ePlex Respiratory Pathogen Panel 2 will aid in the screening of 18 respiratory pathogens, including SARS-CoV-2, to further alleviate the burden on the laboratory as the next influenza season approaches, while providing the clinical team and ultimately patients, the results they need in a rapid actionable time frame.
     

     

    Learning Objectives:

    • Examine the ever changing landscape of laboratory testing for SARS-CoV-2 and other respiratory pathogens in a pandemic setting 
    • Extrapolate how a laboratory might consider algorithm changes with evolving technology and testing options
    • Conceptualize how a broad respiratory pathogen panel with the inclusion of SARS-CoV-2 will improve laboratory efficiency and get clinicians the results they need quickly

     

     

    Webinars will be available for unlimited on-demand viewing after live event.

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources
    Attendees
    • See more